CG Oncology
An Associate Director, Drug Product at CG Oncology leads late-stage development, manufacturing, and commercialization of small molecule and viral drug products. The role involves technical and operational leadership, cross-functional collaboration, and ensuring regulatory compliance across clinical and commercial programs.
CG Oncology is a late-stage biopharmaceutical company focused on developing bladder‑sparing immunotherapies for bladder cancer. The company specializes in oncolytic immunotherapy and is advancing cretostimogene grenadenorepvec as a lead therapeutic candidate. CG Oncology’s programs aim to provide non-surgical, targeted treatment options that preserve the bladder and improve outcomes for patients with bladder cancer. They emphasize clinical development and commercialization readiness to bring these innovative therapies to market.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CG Oncology.
12% above the average for this role
Director, CMC Product Development – Biologics
Beeline Medicines
Director Product Quality Leader
AstraZeneca
Director, CMC Analytical Development – Biologics
Beeline Medicines
Director, Drug Product Development
KOB Solutions, Inc.
Scientist , CMC Process Chemistry
Monte Rosa Therapeutics, Inc
Senior Scientific Advisor - Biosafety
Eurofins